Moderna shares gain after FDA staff backs flu vaccine data

šŸŒ Investing.com (CY) —

AI Summary

Moderna's shares rose after FDA staff endorsed data supporting a new flu vaccine. This development reflects positive market sentiment towards Moderna's vaccine pipeline and healthcare innovation.

Markets Health AI & Tech Moderna FDA flu vaccine share price healthcare innovation vaccine data

Read original source →